ArticleJournal for immunotherapy of cancer2022

Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.

Tim B Fessenden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.